Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

578
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
578
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

551
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
551
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

658
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
658
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

675
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
675
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

704
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
704
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

578
Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per...
578

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness and Safety of Selective Serotonin Reuptake Inhibitors in Individuals with Williams Syndrome.

Journal of child and adolescent psychopharmacology·2026
Same author

From profiles to precision: incorporating the Psychosocial Assessment Tool (PAT) and the Strengths and Difficulties Questionnaire (SDQ) to inform treatment planning in outpatient psychiatry.

European child & adolescent psychiatry·2026
Same author

Deletion size and background genetic variation shape congenital heart disease phenotypes in 3,016 individuals with 22q11.2 deletion syndrome.

medRxiv : the preprint server for health sciences·2026
Same author

Comparison of Autistic and Nonautistic Transgender Youth Attending Psychiatric Clinics Who Request Hormonal Therapy: A Retrospective Pilot Study.

The Israel Medical Association journal : IMAJ·2026
Same author

Multicenter retrospective study on effectiveness, reported side effects, and cognitive outcomes of SSRIs in 22q11.2 deletion syndrome.

Research square·2026
Same author

Resilience Factors and Their Association with Anxiety and Depressive Symptoms: An Intergenerational Perspective.

Psychology research and behavior management·2025
Same journal

Reimagining the Behavioral Health Crisis Care Continuum for Youth.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Addressing the Behavioral Health Needs of Special Populations Within the Youth Crisis Care Continuum.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Technology-Enabled Crisis Care for Youth: Bridging the Gap.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Crisis Phone Services.

Child and adolescent psychiatric clinics of North America·2026
Same journal

A Crisis Care Continuum for Children and Adolescents: The Boston Medical Center Model.

Child and adolescent psychiatric clinics of North America·2026
Same journal

Mobile Response and Stabilization Services.

Child and adolescent psychiatric clinics of North America·2026
See all related articles

Related Experiment Video

Updated: Mar 1, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.8K

Velocardiofacial syndrome.

Doron Gothelf1

  • 1Department of Child Psychiatry, Behavioral Neurogenetics Center, Schneider Children's Medical Center of Israel, Petah Tiqwa, Israel 49202. gothelf@post.tau.ac.il

Child and Adolescent Psychiatric Clinics of North America
|June 15, 2007
PubMed
Summary
This summary is machine-generated.

Velocardiofacial syndrome (VCFS), a common microdeletion, significantly increases schizophrenia risk. This review details VCFS clinical and psychiatric features, developmental aspects, and treatment needs in this high-risk group.

More Related Videos

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.4K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

11.1K

Related Experiment Videos

Last Updated: Mar 1, 2026

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.8K
Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China
08:42

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

4.4K
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

11.1K

Area of Science:

  • Genetics
  • Neuroscience
  • Psychiatry

Background:

  • Velocardiofacial syndrome (VCFS) is the most frequent human microdeletion.
  • VCFS is the leading genetic risk factor for schizophrenia.
  • Understanding VCFS is crucial for managing associated psychiatric conditions.

Purpose of the Study:

  • To outline the clinical characteristics of VCFS.
  • To emphasize psychiatric disorders and behavioral issues from a developmental viewpoint.
  • To discuss potential pathways for psychosis and cognitive deficits in VCFS.

Main Methods:

  • Literature review and synthesis of existing research on VCFS.
  • Clinical case analysis and developmental perspective integration.
  • Discussion of potential etiological pathways for psychiatric symptoms.

Main Results:

  • VCFS presents with diverse clinical features, including significant psychiatric comorbidities.
  • Developmental trajectory reveals increased risk for various psychiatric disorders.
  • Potential neurobiological pathways link VCFS to psychosis and cognitive impairments.

Conclusions:

  • Clinicians should be aware of VCFS as a potential cause of psychiatric symptoms.
  • Current psychiatric treatment research for VCFS is limited.
  • Urgent need for treatment trials in the VCFS high-risk population.